PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Chemical substance: Desloratadine
Presentation Product Chemical substance Chapter Items dispensed
Desloratadine 5mg tablets
0304010ABAAAAAA
Desloratadine Desloratadine Respiratory System 38,928
Neoclarityn 5mg tablets
0304010ABBBAAAA
Neoclarityn Desloratadine Respiratory System 4,504
Desloratadine 2.5mg/5ml oral solution sugar free
0304010ABAAADAD
Desloratadine Desloratadine Respiratory System 2,374
Neoclarityn 2.5mg/5ml oral solution
0304010ABBBACAD
Neoclarityn Desloratadine Respiratory System 263
Desloratadine 2.5mg/5ml oral solution
0304010ABAAABAB
Desloratadine Desloratadine Respiratory System No data available
Midetorin 2.5mg/5ml oral solution (Actavis)
0304010ABBDAAAD
Midetorin Desloratadine Respiratory System No data available
Midetorin 2.5mg/5ml oral solution (Arrow)
0304010ABBDABAD
Midetorin Desloratadine Respiratory System No data available
Neoclarityn 2.5mg/5ml syrup
0304010ABBBABAB
Neoclarityn Desloratadine Respiratory System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.